Viatris (VTRS) Short term Debt (2019 - 2026)
Viatris' (VTRS) quarterly Short term Debt came in at $1.9 billion in Q1 2026, up 15.1% year-on-year from $1.7 billion in Q1 2025, and little changed quarter-over-quarter from $1.9 billion in Q4 2025.
Viatris (VTRS) Short term Debt (2019 - 2026) Analysis & Trends
Viatris' Short term Debt history runs 8 years deep, the most recent figure standing at $1.9 billion for Q1 2026.
- On a quarterly basis, Short term Debt rose 15.1% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $1.9 billion, a 15.1% increase from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 322116.67% from the prior year.
- Short term Debt held at $1.9 billion in Q1 2026 per VTRS's latest filing, from $1.9 billion in the prior quarter.
- Across five years, Short term Debt topped out at $2.0 billion in Q3 2025 and bottomed at $100000.0 in Q3 2023.
- The 5-year median for Short term Debt is $1.7 billion (2024), against an average of $1.2 billion.
- Across the five-year window, Short term Debt slumped 99.99% in 2023 and surged 1673800.0% in 2024, its largest moves.
- Year by year, Short term Debt stood at $1.3 billion in 2022, then soared by 53.66% to $1.9 billion in 2023, then tumbled by 99.97% to $600000.0 in 2024, then soared by 322116.67% to $1.9 billion in 2025, then dropped by 0.29% to $1.9 billion in 2026.
- Per Business Quant, the three latest VTRS Short term Debt figures stand at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.95 Bn |
| Jun 30, 2025 | 1.68 Bn |
| Mar 31, 2025 | 1.67 Bn |
| Dec 31, 2024 | 600,000.00 |
| Sep 30, 2024 | 1.67 Bn |
| Jun 30, 2024 | 1.67 Bn |
| Mar 31, 2024 | 1.90 Bn |
| Dec 31, 2023 | 1.93 Bn |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 23.20 Mn |
| Mar 31, 2023 | 204.60 Mn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 755.00 Mn |
| Jun 30, 2022 | 768.20 Mn |
| Mar 31, 2022 | 655.40 Mn |
| Dec 31, 2021 | 1.86 Bn |
| Sep 30, 2021 | 1.88 Bn |
| Jun 30, 2021 | 1.30 Bn |